Targeted Combination Wins in KRAS-Positive Metastatic Colorectal Cancer

(MedPage Today) -- MADRID -- The combination of a KRAS G12C inhibitor and an EGFR inhibitor significantly improved progression-free survival (PFS) compared with standard treatment in patients with chemorefractory metastatic colorectal cancer...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news